Literature DB >> 16395995

Problems with existing procedures to calculate exact unconditional P-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them.

Joachim Röhmel1.   

Abstract

Recently several papers have been published that deal with the construction of exact unconditional tests for non-inferiority and confidence intervals based on the approximative unconditional restricted maximum likelihood test for two binomial random variables. Soon after the papers have been published the commercially available software for exact tests StatXact has incorporated the new methods. There are however gaps in the proofs which since have not been resolved adequately. Further it turned out that the methods for testing non-inferiority are not coherent and test for non-inferiority can easily come to different conclusions compared to the confidence interval inclusion rule. In this paper, a proposal is made how to resolve the open problems. Berger and Boos (1994) developed the confidence interval method for testing equality of two proportions. StatXact (Version 5) has extended this method for shifted hypotheses. It is shown that at least for unbalanced designs (i.e. largely different sample sizes) the Berger and Boos method can lead to controversial results.

Mesh:

Year:  2005        PMID: 16395995     DOI: 10.1002/bimj.200410086

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  3 in total

1.  Exact p-values for Simon's two-stage designs in clinical trials.

Authors:  Guogen Shan; Hua Zhang; Tao Jiang; Hanna Peterson; Daniel Young; Changxing Ma
Journal:  Stat Biosci       Date:  2016-06-16

2.  Boundary problem in Simon's two-stage clinical trial designs.

Authors:  Guogen Shan; John J Chen; Changxing Ma
Journal:  J Biopharm Stat       Date:  2016-02-16       Impact factor: 1.051

3.  Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar's or sign tests.

Authors:  Michael P Fay; Keith Lumbard
Journal:  Stat Med       Date:  2020-12-01       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.